Skip to content

Public FDA record

Z-0971-2019: ARCHITECT MAGNESIUM, (a) REF 7D70-21, (b) 7D70-31 The Magnesium assay is used for the quantitation of ma

Recall record Z-0971-2019 for Abbott Laboratories, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0971-2019
Company in FDA record
Abbott Laboratories, Inc
FDA record creation date
Mar 1, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Abbott internal testing has identified that the Magnesium urine application demonstrates depressed urine result recovery. All samples >0.5mEq/L fail the linearity acceptance criteria for the bias specification and demonstrate depressed recovery of up to 37%. The specific cause of the negative bias/depressed results is currently under investigation.

Source facts

Action
The firm, Abbott, initiated the recall by letter on 01/02/2018 titled '"Product Correction Urgent-Immediate Action Required" by its customers. The letter explained the issue, described the product and actions to be taken. The customers were instructed to do the following: -Immediately discontinue use of the ARCHITECT Magnesium (LN 7D70) urine application. - You may continue to use the serum/plasma application for the ARCHITECT Magnesium (LN 7D70). -Please review this letter with your Medical Director or Laboratory Management and follow your laboratory protocol regarding the need for reviewing previously reported patient results. -Complete and return the Customer Reply Form prior to January 17, 2019 via FAX #: 18007770051 or email QAGCO@abbott.com. Even if you no longer have the instrument(s),. -If you have forwarded the product listed above to other laboratories, please inform them of this Product Correction and provide to them a copy of this letter. -As an alternative to the current urine application, you may use Abbott ARCHITECT (enzymatic) Magnesium LN 3P68, urine application, where available. If you or any of the health care providers you serve have any questions regarding this information, U.S. Customers please contact Customer Service at 18774ABBOTT (available 24 hours a day, 7 days a week). Customers outside the U.S., please contact your local area Customer Service.
Initiated
2019-01-02
Root cause
Under Investigation by firm
Terminated
2021-06-30
Distribution
Worldwide Distribution: US (nationwide) and to countries of: CHINA, THAILAND, GUATEMALA, and EL SALVADOR.
Recall number
Z-0971-2019
Recall status
Terminated
CDRH record ID
170338
FDA record created
2019-03-01
Recall event number
81929

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗